Paper - WANFANG MED ONLINE

You Position: Home > Paper

High density lipoprotein - 3 in diabetic retinopathy patients: relationship to total antioxidant capacity and nitric oxide level

( views:68, downloads:39 )

Author:: No author available

Journal Title:: International Eye Science

Issue:: 12

DOI:: 10.3980/j.issn.1672-5123.2017.12.03

Key Word:: 高密度脂蛋白;糖尿病视网膜病变;一氧化氮;总抗氧化;high density lipoprotein;diabetic retinopathy;nitric oxide;total antioxidant

Abstract： ·AIM: To examine the association between high density lipoprotein ( HDL) 3 cholesterol, nitrite plus nitrate ( NOx) and total antioxidant status in diabetic retinopathy patients compared to controls.·METHODS:This was a prospective, case-control study. One hundred and six participants were subdivided into three groups. Eighty-four type 2 diabetes patients with and without retinopathy and 22 healthy controls were included in this study. Serum HDL3 concentrations were assayed and serum NOx levels were determined in all patients. Total antioxidant capacity was measured using the ferric reducing power of plasma ( FRAP) assay.·RESULTS: Among the subjects with diabetes mellitus (DM), fasting glucose, HbA1c and triglycerides were significantly higher than the healthy controls. HDL3 level was 14. 4 ( 12. 0 ) mg/dl in healthy subjects, 18. 1 ( 12. 6 ) mg/dl in the diabetic retinopathy group and 14. 0 (12. 5) mg/dl in diabetic patients without retinopathy, and was statistically similar between the groups (P=0. 262). HDL level was similar between groups in our population. FRAP level was lower in patients with DM compared to healthy controls (P=0. 003), but was not different between the DR and the non-DR groups (P=0. 913).·CONCLUSION:In our study, we demonstrated that HDL and HDL3 subgroup levels didn't significantly differ between DM2 patients with DR and without DR and healthy controls. Determination of HDL3 cholesterol, in addition to total HDL cholesterol, may not predict the actual risk for diabetic retinopathy. Serum NOx was observed to be higher in diabetic participants and FRAP level was low.

Reference

[1]Amrita, Ghosh,Mingma L, Sherpa,Yazum, Bhutia,etc.Serum nitric oxide status in patients with type 2 diabetes mellitus in Sikkim.[J].2011,1(1).
[2]Petrovic, Mojca Globocnik,Kruzliak, Peter,Petrovic, Daniel.The rs6060566 of the reactive oxygen species modulator 1 (Romo-1) gene affects Romo-1 expression and the development of diabetic retinopathy in Caucasians with type 2 diabetes[J].2015,93(8).
[3]Riwanto,M.,Landmesser,U..Thematic review series: High density lipoprotein structure, function, and metabolism: High density lipoproteins and endothelial functions: Mechanistic insights and alterations in cardiovascular disease[J].2013,54(12).
[4]Silva RA,Kontush A,Davidson WS,etc.Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function.[J].2009,29(6).
[5]Frank M Sacks,Michel P Hermans,Paola Fioretto,etc.Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.[J].2014,129(9).
[6]Zhi-Peng Yan,Jing-Xue Ma.Risk factors for diabetic retinopathy in northern Chinese patients with type 2 diabetes mellitus[J].2016,(8).
[7]Conghui, Zhang,Hao, Wang,Jing, Nie,etc.Protective factors in diabetic retinopathy: focus on blood-retinal barrier.[J].2014,18(98).
[8]Obrosova IG,Mabley JG,Szabo C,etc.Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.[J].2005,12(3).
[9]Kontush, Anatol,Zakiev, Emile,Orekhov, Alexander,etc.Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c[J].2017,1862(2).
[10]Filippatos,T.D.,Rizos,E.C.,Tsimihodimos,V.,etc.Small high-density lipoprotein (HDL) subclasses are increased with decreased activity of HDL-associated phospholipase A2 in subjects with prediabetes[J].2013,48(6).
[11]Klein, Ronald,Myers, Chelsea E.,Lee, Kristine E.,etc.Oxidized Low-Density Lipoprotein and the Incidence of Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema Determined From Fundus Photographs[J].2015,133(9).
[12]Landmesser U,Drexler H,Hornig B.Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions.[J].2000,26(5).
[13]Shaoyan, Jiang,Dan, Li,Jian, Li,etc.Correlation Between High-Density Lipoprotein and Monocyte Subsets in Patients with Stable Coronary Heart Disease.[J].2015,21.
[14]Sobha, Sivaprasad,Bhaskar, Gupta,Martin C, Gulliford,etc.Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK).[J].2012,7(3).
[15]Lucia Cutuli,Angela Pirillo,Patrizia Uboldi,etc.15-lipoxygenase-mediated modification of HDL3 impairs eNOS activation in human endothelial cells.[J].2014,49(4).
[16]Puspalata, Agroiya,Rajeev, Philip,Sanjay, Saran,etc.Association of serum lipids with diabetic retinopathy in type 2 diabetes.[J].2013,17(Suppl 1).
[17]Katrina M. Miranda,Michael G. Espey,David A. Wink.A Rapid, Simple Spectrophotometric Method for Simultaneous Detection of Nitrate and Nitrite[J].2001,5(1).
[18]Folami, Lamoke,Sean, Shaw,Jianghe, Yuan,etc.Increased Oxidative and Nitrative Stress Accelerates Aging of the Retinal Vasculature in the Diabetic Retina.[J].2015,10(10).
[19]Kulaksizoglu, Sevsen,Karalezli, Aylin.Aqueous Humour and Serum Levels of Nitric Oxide, Malondialdehyde and Total Antioxidant Status in Patients with Type 2 Diabetes with Proliferative Diabetic Retinopathy and Nondiabetic Senile Cataracts[J].2016,40(2).
[20]Chamberlain, James J.,Rhinehart, Andrew S.,Shaefer, Charles F., Jr.,etc.Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes[J].2016,164(8).
[21]de Souza JA,Vindis C,Negre Salvayre A,etc.Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I.[J].2010,14(3).
[22]Bakogianni MC,Kalofoutis CA,Skenderi KI,etc.Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease.[J].2001,15(5).
[23]Vadas MA,Barter PJ,Rye KA,etc.Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression.[J].2000,41(8).
[24]Crispim, Daisy,Boucas, Ana P.,Canani, Luis H.,etc.Nitric oxide levels in patients with diabetes mellitus: A systematic review and meta-analysis[J].2016,61.
[25]Guzman, David Calder��n,Olgu��n, Hugo Ju��rez,Garc��a, Ernestina Hern��ndez,etc.Mechanisms involved in the development of diabetic retinopathy induced by oxidative stress.[J].2017,22(1).
[26]Tasci, Ilker,Saglam, Kenan,Basgoz, Bilgin Bahadir.Glycemic control and the risk of microvascular complications in people with diabetes mellitus[J].2016,53(1).
[27]d'Orleans Juste P,Kermorvant Duchemin E,Chemtob S,etc.Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration.[J].2005,11(12).
[28]Anatol, Kontush,Patrice, Therond,Amal, Zerrad,etc.Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities.[J].2007,27.
[29]Hwang, You-Cheol,Hayashi, Tomoshige,Fujimoto, Wilfred Y.,etc.Differential Association Between HDL Subclasses and the Development of Type 2 Diabetes in a Prospective Study of Japanese Americans[J].2015,38(11).
[30]Mori F,Nagaoka T,Takahashi A,etc.Relation between plasma nitric oxide levels and diabetic retinopathy.[J].2006,50(5).
[31]Ting, D. S.,Tan, K. A.,Phua, V.,etc.Biomarkers of Diabetic Retinopathy[J].2016,16(12).
[32]Javeria, Amin,Muhammad, Sharif,Mussarat, Yasmin.A Review on Recent Developments for Detection of Diabetic Retinopathy.[J].2016,(Spec ).
[33]Esin, Eren,Necat, Yilmaz,Ozgur, Aydin.High Density Lipoprotein and it's Dysfunction.[J].2012,6.
[34]Nahomi,R.B.,Palmer,A.,Green,K.M.,etc.Pro-inflammatory cytokines downregulate Hsp27 and cause apoptosis of human retinal capillary endothelial cells[J].2014,1842(2).
[35]Suchitra Mustur, Manohar,Seshadri Reddy, Vaikasuvu,K, Deepthi,etc.An association of hyperglycemia with plasma malondialdehyde and atherogenic lipid risk factors in newly diagnosed Type 2 diabetic patients.[J].2013,18(2).
[36]Juliana A. de Souza,Cecile Vindis,Boris Hansel,etc.Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity[J].2008,197(1).
[37]A Jamuna, Rani,S V, Mythili.Study on total antioxidant status in relation to oxidative stress in type 2 diabetes mellitus.[J].2014,8(3).
[38]Daniel Petrovic.Candidate Genes for Proliferative Diabetic Retinopathy[J].2013,(Pt.18).
[39]Anouar Hafiane,Jacques Genest.High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk[J].2015,3.
[40]Yang,S.,Chen,J.,Du,M.,etc.Mechanisms of modified LDL-Induced pericyte loss and retinal injury in diabetic retinopathy[J].2012,55(11).
[41]Savli H,Sevinc A,Turkoz Y,etc.Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.[J].2002,16(2).
[42]Zerrad Saadi A,Therond P,Chantepie.HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis.[J].2009,29(12).
[43]Anatol, Kontush,Sandrine, Chantepie,M John, Chapman.Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.[J].2003,23.
[44]Sharma, Shashi,Saxena, Sandeep,Srivastav, Khushboo,etc.Nitric oxide and oxidative stress is associated with severity of diabetic retinopathy and retinal structural alterations[J].2015,43(5).